NCT03451032View on ClinicalTrials.gov

Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Hiv
Interventions
OTHER

Non Interventional Study

Non Interventional Study

Trial Locations (6)

44093

Nantes University Hospital, Nantes

44600

Saint-Nazaire Hospital, Saint-Nazaire

49000

Angers University Hospital, Angers

53000

Laval Hospital, Laval

72000

Le Mans Hospital, Le Mans

85000

La Roche sur Yon Hospital, La Roche-sur-Yon

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03451032 - Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV | Biotech Hunter | Biotech Hunter